Biomarkers of Chinese advanced cancer patients based on real-world data: Actionable genomic alterations and tumor mutational burden.

被引：0
|
作者：
Wang, HaiTao
Wang, Huina
Guo, Rongyun
Li, Mingwei
Zhang, Yanrui
Lou, Feng
Cao, Shanbo
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14280
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness
    Quintanilha, Julia C. F.
    Storandt, Michael H.
    Graf, Ryon P.
    Li, Gerald
    Keller, Rachel
    Lin, Douglas I.
    Ross, Jeffrey S.
    Huang, Richard S. P.
    Schrock, Alexa B.
    Oxnard, Geoffrey R.
    Chakrabarti, Sakti
    Mahipal, Amit
    JCO PRECISION ONCOLOGY, 2023, 7
  • [2] Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma
    Chen, Xusheng
    Ou, Zhenyu
    Wang, Lei
    Zhang, Zhenting
    Fan, Xiaodong
    Liu, Huanhuan
    Wang, Wenping
    Zhang, Yanrui
    Zhu, Jun
    Liang, Xiayuan
    Lou, Feng
    Cao, Shanbo
    Yao, Ye
    Wang, Huina
    Yao, Xin
    MOLECULAR CARCINOGENESIS, 2022, 61 (03) : 311 - 321
  • [3] Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing
    Gabriel Roman Souza
    Ahmed Abdalla
    Sukeshi Arora
    Daruka Mahadevan
    Investigational New Drugs, 2022, 40 : 643 - 649
  • [4] Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing
    Souza, Gabriel Roman
    Abdalla, Ahmed
    Arora, Sukeshi
    Mahadevan, Daruka
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (03) : 643 - 649
  • [5] Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations
    Takeda, Hiroyuki
    Yamamoto, Hiroyuki
    Oikawa, Ritsuko
    Umemoto, Kumiko
    Arai, Hiroyuki
    Mizukami, Takuro
    Ogawa, Kazuki
    Uchida, Yoshiyasu
    Nagata, Yusuke
    Kubota, Yohei
    Doi, Ayako
    Horie, Yoshiki
    Ogura, Takashi
    Izawa, Naoki
    Moore, Jay A.
    Sokol, Ethan S.
    Sunakawa, Yu
    JCO PRECISION ONCOLOGY, 2024, 8
  • [6] Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort
    Papillon-Cavanagh, Simon
    Gao, Chuan
    Han, G. Celine
    Walsh, Alice M.
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Comprehensive Genomic Profiling of Tumor Mutational Burden-high in Chinese Lung Cancer Patients
    Li, W.
    Liu, B.
    Liu, C.
    Li, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S608 - S609
  • [8] Urine-based comprehensive genomic profiling reveals mutational landscape in real-world patients with bladder cancer
    Chen, H.
    Zhang, R.
    Tang, H.
    Zang, J.
    Jin, D.
    Qian, L.
    Zhang, T.
    Xie, F.
    Zhang, X.
    Zhang, Y.
    Jia, S.
    Zhuang, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1222 - S1222
  • [9] Tumor mutational burden (TMB) in real-world patients with pancreatic ductal adenocarcinoma (PDAC): Differences in genomic alterations (GA) and predictive value for immune checkpoint inhibitor (ICI) effectiveness
    Mahipal, Amit
    Quintanilha, Julia C. F.
    Graf, Ryon
    Storandt, Michael H.
    Keller, Rachel B.
    Li, Gerald
    Ross, Jeffrey S.
    Huang, Richard S. P.
    Schrock, Alexa Betzig
    Oxnard, Geoffrey R.
    Chakrabarti, Sakti
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients
    Gerald, Thomas
    Margulis, Vitaly
    Meng, Xiaosong
    Bagrodia, Aditya
    Cole, Suzanne
    Qin, Qian
    Call, S. Greg
    Mauer, Elizabeth
    Lotan, Yair
    Woldu, Solomon L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 148.e17 - 148.e24
12345